The purpose of this training program in the Department of Gynecologic Oncology of the The University of Texas M.D. Anderson Cancer Center is to produce academic gynecologic oncologists. Candidates will hold an M.D or M.D./Ph.D. degree and be board eligible in obstetrics and gynecology and the subspecialty of gynecologic oncology. Moreover, the program is committed to providing research opportunities to groups that are underrepresented in academic gynecologic oncology, including minority individuals and women. A 4-year training program is offered. The curriculum will include 24 months of research training followed by 24 months of clinical training in gynecologic oncology. Two different types of research training will be offered: 1) a physician-scientist track in which trainees will spend 24 months in the laboratory, and 2) a population-based research track in which trainees will spend 24 months under the direction of one or two of the faculty mentors;the latter track may include either one year of laboratory-based research followed by a year of population-based research or two years of population-based research. In addition, during the research portion of the training program, each fellow will be required to complete a core of three courses as well as obtain an advanced degree-either an M.S. degree or M.P.H. degree-in the Graduate School of Biomedical Sciences or the UT School of Public Health, respectively. The mentors in this training program-physician-scientists and research scientists with active research programs supported by external peer-reviewed funding-are committed to a high quality research experience focused on gynecologic cancers. A broad range of research opportunities are available in cancer biology, molecular therapeutics, biostatistics, cancer prevention, tumor immunology, molecular and cellular oncology, behavior sciences, cancer genetics, health disparities, health services research, and epidemiology. It is expected that graduates of this highly competitive training program will be future leaders in the discipline and play a major role in setting patient care, research, and educational agendas of future generations of gynecologic oncologists.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA101642-05
Application #
7682313
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lim, Susan E
Project Start
2005-09-15
Project End
2010-08-31
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
5
Fiscal Year
2009
Total Cost
$377,721
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Other Health Professions
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Taylor, Jolyn S; He, Weiguo; Harrison, Ross et al. (2018) Disparities in treatment and survival among elderly ovarian cancer patients. Gynecol Oncol 151:269-274
Hillman, R Tyler; Chisholm, Gary B; Lu, Karen H et al. (2018) Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer. J Natl Cancer Inst 110:
Jazaeri, Amir; Coleman, Robert L; Sood, Anil K et al. (2018) A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice. Gynecol Oncol 151:374-380
Allen, Julie K; Armaiz-Pena, Guillermo N; Nagaraja, Archana S et al. (2018) Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction. Cancer Res 78:3233-3242
Armbruster, Shannon D; Song, Jaejoon; Gatus, Leticia et al. (2018) Endometrial cancer survivors' sleep patterns before and after a physical activity intervention: A retrospective cohort analysis. Gynecol Oncol 149:133-139
Huang, Yan; Hu, Wei; Huang, Jie et al. (2018) Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer. Mol Cancer Ther 17:464-473
Armbruster, Shannon D; Sun, Charlotte C; Westin, Shannon N et al. (2018) Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration. Gynecol Oncol 149:484-490
Hinchcliff, Emily; Hong, David; Le, Hung et al. (2018) Characteristics and outcomes of patients with recurrent ovarian cancer undergoing early phase immune checkpoint inhibitor clinical trials. Gynecol Oncol 151:407-413
Meyer, Larissa A; He, Weiguo; Sun, Charlotte C et al. (2018) Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness. Gynecol Oncol 150:451-459
Bergstrom, Jennifer; Aloisi, Alessia; Armbruster, Shannon et al. (2018) Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers. Gynecol Oncol 148:480-484

Showing the most recent 10 out of 295 publications